# CIRCLE8 Group Inc: financial statements, quarterly

CIRC · Nasdaq · CIK 1605888 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/circ.md) · [Financials](/companies/circ/financials.md) · [Filings](/companies/circ/filings.md) · [Insiders](/companies/circ/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/circ/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [97.8](/filings/0001605888-24-000012.md) | [116 d](/filings/0001605888-25-000006.md) | [101](/filings/0001605888-25-000019.md) | [105](/filings/0001605888-25-000031.md) | [108](/filings/0001605888-25-000055.md) | [130 d](/filings/0001605888-26-000017.md) | [103](/filings/0001605888-26-000025.md) | [103](/filings/0001605888-26-000044.md) | [110](/filings/0001605888-25-000055.md) | [120 d](/filings/0001605888-26-000017.md) | [250](/filings/0001605888-26-000025.md) | [320](/filings/0001605888-26-000044.md) |
| Cost of revenue | $m | [86.2](/filings/0001605888-24-000012.md) | [(251) d](/filings/0001213900-24-031701.md) | [90.2](/filings/0001605888-25-000019.md) | [93.1](/filings/0001213900-24-069169.md) | [95.9](/filings/0001605888-25-000055.md) | [116 d](/filings/0001605888-26-000017.md) | [91.6](/filings/0001605888-26-000025.md) | [91.5](/filings/0001605888-26-000044.md) | [97.7](/filings/0001605888-25-000055.md) | [109 d](/filings/0001605888-26-000017.md) | [228](/filings/0001605888-26-000025.md) | [296](/filings/0001605888-26-000044.md) |
| Gross profit | $m | [11.6](/filings/0001605888-24-000012.md) | [12.6 d](/filings/0001605888-25-000006.md) | [10.5](/filings/0001605888-25-000019.md) | [11.5](/filings/0001605888-25-000031.md) | [11.9](/filings/0001605888-25-000055.md) | [13.3 d](/filings/0001605888-26-000017.md) | [11.2](/filings/0001605888-26-000025.md) | [11.4](/filings/0001605888-26-000044.md) | [12.4](/filings/0001605888-25-000055.md) | [11.0 d](/filings/0001605888-26-000017.md) | [21.4](/filings/0001605888-26-000025.md) | [23.8](/filings/0001605888-26-000044.md) |
| Research and development | $m | [0.4](/filings/0001213900-23-088775.md) | [0.5 d](/filings/0001213900-24-031701.md) | [0.3](/filings/0001213900-24-044770.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [10.4](/filings/0001605888-24-000012.md) | [13.7 d](/filings/0001605888-25-000006.md) | [10.3](/filings/0001605888-25-000019.md) | [18.6](/filings/0001605888-25-000031.md) | [17.2](/filings/0001605888-25-000055.md) | [18.0 d](/filings/0001605888-26-000017.md) | [19.4](/filings/0001605888-26-000025.md) | [18.9](/filings/0001605888-26-000044.md) | [19.9](/filings/0001605888-25-000055.md) | [33.1 d](/filings/0001605888-26-000017.md) | [32.0](/filings/0001605888-26-000025.md) | [34.8](/filings/0001605888-26-000044.md) |
| Operating income | $m | [(0.4)](/filings/0001605888-24-000012.md) | [(2.4) d](/filings/0001605888-25-000006.md) | [(1.1)](/filings/0001605888-25-000019.md) | [(8.3)](/filings/0001605888-25-000031.md) | [(6.5)](/filings/0001605888-25-000055.md) | [(5.9) d](/filings/0001605888-26-000017.md) | [(9.4)](/filings/0001605888-26-000025.md) | [(8.7)](/filings/0001605888-26-000044.md) | [(8.7)](/filings/0001605888-25-000055.md) | [(23.4) d](/filings/0001605888-26-000017.md) | [(14.9)](/filings/0001605888-26-000025.md) | [(15.4)](/filings/0001605888-26-000044.md) |
| Interest expense | $m | [0.0](/filings/0001213900-23-088775.md) | [17.5 d](/filings/0001605888-25-000006.md) | [5.0](/filings/0001605888-25-000019.md) | [4.0](/filings/0001605888-25-000031.md) | [1.5](/filings/0001605888-25-000055.md) | [1.5 d](/filings/0001605888-26-000017.md) | [1.3](/filings/0001605888-26-000025.md) | [2.0](/filings/0001605888-26-000044.md) | [2.1](/filings/0001605888-25-000055.md) | [3.8 d](/filings/0001605888-26-000017.md) | [3.6](/filings/0001605888-26-000025.md) | [4.3](/filings/0001605888-26-000044.md) |
| Income tax | $m | [(1.3)](/filings/0001605888-24-000012.md) | [(2.1) d](/filings/0001605888-25-000006.md) | [(1.3)](/filings/0001605888-25-000019.md) | [(17.2)](/filings/0001605888-25-000031.md) | [(1.2)](/filings/0001605888-25-000055.md) | [25.1 d](/filings/0001605888-26-000017.md) | [0.0](/filings/0001605888-26-000025.md) | [0.0](/filings/0001605888-26-000044.md) | [0.0](/filings/0001605888-25-000055.md) | [0.0 d](/filings/0001605888-26-000017.md) | [(0.1)](/filings/0001605888-26-000025.md) | [(1.4)](/filings/0001605888-26-000044.md) |
| Net income | $m | [(3.9)](/filings/0001605888-24-000012.md) | [(5.4) d](/filings/0001605888-25-000006.md) | [(4.9)](/filings/0001605888-25-000055.md) | [(54.9)](/filings/0001605888-25-000055.md) | [(7.0)](/filings/0001605888-25-000055.md) | [(68.7) d](/filings/0001605888-26-000017.md) | [(10.7)](/filings/0001605888-26-000025.md) | [(10.7)](/filings/0001605888-26-000044.md) | [(10.8)](/filings/0001605888-25-000055.md) | [(27.1) d](/filings/0001605888-26-000017.md) | [(30.7)](/filings/0001605888-26-000044.md) | [(86.4)](/filings/0001605888-26-000044.md) |
| Diluted EPS | $ per share | [(0.15)](/filings/0001605888-24-000012.md) | not reported | [(0.19)](/filings/0001605888-25-000019.md) | [(1.96)](/filings/0001605888-25-000031.md) | [(0.16)](/filings/0001605888-25-000055.md) | not reported | [(0.20)](/filings/0001605888-26-000025.md) | [(0.20)](/filings/0001605888-26-000044.md) | [(0.20)](/filings/0001605888-25-000055.md) | not reported | [(0.44)](/filings/0001605888-26-000025.md) | [(0.98)](/filings/0001605888-26-000044.md) |
| Basic EPS | $ per share | [(0.15)](/filings/0001605888-24-000012.md) | not reported | [(0.19)](/filings/0001605888-25-000019.md) | [(1.96)](/filings/0001605888-25-000031.md) | [(0.16)](/filings/0001605888-25-000055.md) | not reported | [(0.20)](/filings/0001605888-26-000025.md) | [(0.20)](/filings/0001605888-26-000044.md) | [(0.20)](/filings/0001605888-25-000055.md) | not reported | [(0.44)](/filings/0001605888-26-000025.md) | [(0.98)](/filings/0001605888-26-000044.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold, us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [3.7](/filings/0001213900-23-088775.md) | [1.4](/filings/0001605888-25-000006.md) | [1.7](/filings/0001213900-24-044770.md) | [0.4](/filings/0001213900-24-069169.md) | [1.4](/filings/0001605888-24-000012.md) | [0.7](/filings/0001605888-26-000017.md) | [1.5](/filings/0001605888-25-000019.md) | [0.4](/filings/0001605888-25-000031.md) | [0.1](/filings/0001605888-25-000055.md) | [0.1](/filings/0001605888-26-000044.md) | [24.1](/filings/0001605888-26-000025.md) | [19.3](/filings/0001605888-26-000044.md) |
| Current assets | $m | [3.7](/filings/0001213900-23-088775.md) | [78.8](/filings/0001605888-25-000006.md) | [1.7](/filings/0001213900-24-044770.md) | [72.7](/filings/0001213900-24-069169.md) | [74.5](/filings/0001605888-24-000012.md) | [85.0](/filings/0001605888-26-000017.md) | [72.7](/filings/0001605888-25-000019.md) | [68.1](/filings/0001605888-25-000031.md) | [71.7](/filings/0001605888-25-000055.md) | [81.2](/filings/0001605888-26-000044.md) | [328](/filings/0001605888-26-000025.md) | [331](/filings/0001605888-26-000044.md) |
| Total assets | $m | [5.5](/filings/0001213900-23-088775.md) | [127](/filings/0001605888-25-000006.md) | [3.4](/filings/0001213900-24-044770.md) | [134](/filings/0001213900-24-069169.md) | [136](/filings/0001605888-24-000012.md) | [120](/filings/0001605888-26-000017.md) | [106](/filings/0001605888-25-000019.md) | [107](/filings/0001605888-25-000031.md) | [110](/filings/0001605888-25-000055.md) | [113](/filings/0001605888-26-000044.md) | [981](/filings/0001605888-26-000025.md) | [966](/filings/0001605888-26-000044.md) |
| Current liabilities | $m | [1.0](/filings/0001213900-23-088775.md) | [162](/filings/0001605888-25-000006.md) | [2.5](/filings/0001213900-24-044770.md) | [68.4](/filings/0001213900-24-069169.md) | [81.8](/filings/0001605888-24-000012.md) | [94.2](/filings/0001605888-26-000017.md) | [117](/filings/0001605888-25-000019.md) | [52.0](/filings/0001605888-25-000031.md) | [58.2](/filings/0001605888-25-000055.md) | [115](/filings/0001605888-26-000044.md) | [836](/filings/0001605888-26-000025.md) | [843](/filings/0001605888-26-000044.md) |
| Total liabilities | $m | [3.8](/filings/0001213900-23-088775.md) | [166](/filings/0001605888-25-000006.md) | [3.8](/filings/0001213900-24-044770.md) | [111](/filings/0001213900-24-069169.md) | [119](/filings/0001605888-24-000012.md) | [132](/filings/0001605888-26-000017.md) | [121](/filings/0001605888-25-000019.md) | [125](/filings/0001605888-25-000031.md) | [132](/filings/0001605888-25-000055.md) | [145](/filings/0001605888-26-000044.md) | [926](/filings/0001605888-26-000025.md) | [988](/filings/0001605888-26-000044.md) |
| Long-term debt | $m | not reported | [0.0](/filings/0001605888-25-000006.md) | not reported | [41.5](/filings/0001213900-24-069169.md) | [36.7](/filings/0001605888-24-000012.md) | [36.7](/filings/0001605888-26-000017.md) | [2.0](/filings/0001605888-25-000019.md) | [72.0](/filings/0001605888-25-000031.md) | [73.1](/filings/0001605888-25-000055.md) | [28.8](/filings/0001605888-26-000044.md) | [44.7](/filings/0001605888-26-000025.md) | [109](/filings/0001605888-26-000044.md) |
| Current portion of debt | $m | not reported | [139](/filings/0001605888-25-000006.md) | not reported | [37.0](/filings/0001213900-24-069169.md) | [44.2](/filings/0001605888-24-000012.md) | [43.9](/filings/0001605888-26-000017.md) | [64.9](/filings/0001605888-25-000019.md) | [3.3](/filings/0001605888-25-000031.md) | [3.3](/filings/0001605888-25-000055.md) | [55.8](/filings/0001605888-26-000044.md) | [469](/filings/0001605888-26-000025.md) | [457](/filings/0001605888-26-000044.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001605888-26-000044.md) | not reported | not reported | not reported | [2.5](/filings/0001605888-26-000044.md) |
| Shareholders' equity | $m | [(31.9)](/filings/0001605888-24-000012.md) | [(39.4)](/filings/0001605888-26-000017.md) | [16.8](/filings/0001605888-25-000055.md) | [23.0](/filings/0001605888-25-000055.md) | [16.2](/filings/0001605888-25-000055.md) | [(12.0)](/filings/0001605888-26-000044.md) | [(14.0)](/filings/0001605888-26-000044.md) | [(18.5)](/filings/0001605888-26-000044.md) | [(22.1)](/filings/0001605888-25-000055.md) | [(32.1)](/filings/0001605888-26-000044.md) | [42.4](/filings/0001605888-26-000044.md) | [(25.5)](/filings/0001605888-26-000044.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(6.5) d](/filings/0001605888-24-000012.md) | [(11.7) d](/filings/0001605888-25-000006.md) | [11.2](/filings/0001605888-25-000019.md) | [(15.5) d](/filings/0001605888-25-000031.md) | [(1.3) d](/filings/0001605888-25-000055.md) | [(0.4) d](/filings/0001605888-26-000017.md) | [14.6](/filings/0001605888-26-000025.md) | [(9.5) d](/filings/0001605888-26-000044.md) | [(1.3) d](/filings/0001605888-25-000055.md) | [(8.2) d](/filings/0001605888-26-000017.md) | [(9.9)](/filings/0001605888-26-000025.md) | [(3.8) d](/filings/0001605888-26-000044.md) |
| Capital expenditure | $m | [0.0 d](/filings/0001605888-24-000012.md) | [(0.0) d](/filings/0001605888-25-000006.md) | [0.0](/filings/0001605888-25-000019.md) | [0.0 d](/filings/0001605888-25-000031.md) | [0.0 d](/filings/0001605888-25-000055.md) | [0.0 d](/filings/0001605888-26-000017.md) | [0.0](/filings/0001605888-26-000025.md) | [0.0 d](/filings/0001605888-26-000044.md) | [0.0 d](/filings/0001605888-25-000055.md) | [0.0 d](/filings/0001605888-26-000017.md) | [0.0](/filings/0001605888-26-000025.md) | [0.0 d](/filings/0001605888-26-000044.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [0.3](/filings/0001213900-23-088775.md) | [0.4](/filings/0001213900-24-044770.md) | [25.4](/filings/0001213900-24-069169.md) | [25.4](/filings/0001605888-24-000012.md) | [25.4](/filings/0001605888-25-000019.md) | [28.1](/filings/0001605888-25-000031.md) | [44.7](/filings/0001605888-25-000055.md) | [54.0](/filings/0001605888-26-000025.md) | [54.6](/filings/0001605888-26-000044.md) | [55.1](/filings/0001605888-25-000055.md) | [74.0](/filings/0001605888-26-000025.md) | [81.0](/filings/0001605888-26-000044.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 114,406,923 at 2026-08-14, from the cover of the [10-Q filed 2026-08-19](/filings/0001605888-26-000044.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.